(Total Views: 478)
Posted On: 02/28/2019 10:31:40 AM
Post# of 150

$HZNP News Article - Horizon Pharma plc Announces Phase 3 Confirmatory Trial Evaluating Teprotumumab (OPTIC) for the Treatment of Active Thyroid Eye Disease (TED) Met Primary and All Secondary Endpoints https://marketwirenews.com/news-releases/hori...75328.html


My Twitter: WhyteStocks